Show simple item record

dc.contributor.authorGarvey, John F
dc.contributor.authorMcNicholas, Walter T
dc.date.accessioned2010-10-05T12:27:35Z
dc.date.available2010-10-05T12:27:35Z
dc.date.issued2010-02
dc.identifier.citationContinuous positive airway pressure therapy: new generations. 2010, 131:259-66 Indian J. Med. Res.en
dc.identifier.issn0971-5916
dc.identifier.pmid20308751
dc.identifier.urihttp://hdl.handle.net/10147/112320
dc.description.abstractContinuous positive airway pressure (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS). However, CPAP is not tolerated by all patients with OSAS and alternative modes of pressure delivery have been developed to overcome pressure intolerance, thereby improving patient comfort and adherence. Auto-adjustable positive airway pressure (APAP) devices may be utilised for the long-term management of OSAS and may also assist in the initial diagnosis of OSAS and titration of conventional CPAP therapy. Newer modalities such as C-Flex and A-Flex also show promise as treatment options in the future. However, the evidence supporting the use of these alternative modalities remains scant, in particular with regard to long-term cardiovascular outcomes. In addition, not all APAP devices use the same technological algorithms and data supporting individual APAP devices cannot be extrapolated to support all. Further studies are required to validate the roles of APAP, C-Flex and A-Flex. In the interim, standard CPAP therapy should continue as the mainstay of OSAS management.
dc.language.isoenen
dc.subject.meshAlgorithms
dc.subject.meshCardiovascular Diseases
dc.subject.meshContinuous Positive Airway Pressure
dc.subject.meshEquipment Design
dc.subject.meshHumans
dc.subject.meshPositive-Pressure Respiration
dc.subject.meshQuality of Life
dc.subject.meshResearch
dc.subject.meshSleep Apnea, Obstructive
dc.subject.meshTreatment Outcome
dc.titleContinuous positive airway pressure therapy: new generations.en
dc.contributor.departmentSleep Research Laboratory, St. Vincent's University Hospital, Dublin, Ireland. john.garvey@ucd.ieen
dc.identifier.journalThe Indian journal of medical researchen
refterms.dateFOA2018-08-22T09:24:05Z
html.description.abstractContinuous positive airway pressure (CPAP) is the treatment of choice for obstructive sleep apnoea syndrome (OSAS). However, CPAP is not tolerated by all patients with OSAS and alternative modes of pressure delivery have been developed to overcome pressure intolerance, thereby improving patient comfort and adherence. Auto-adjustable positive airway pressure (APAP) devices may be utilised for the long-term management of OSAS and may also assist in the initial diagnosis of OSAS and titration of conventional CPAP therapy. Newer modalities such as C-Flex and A-Flex also show promise as treatment options in the future. However, the evidence supporting the use of these alternative modalities remains scant, in particular with regard to long-term cardiovascular outcomes. In addition, not all APAP devices use the same technological algorithms and data supporting individual APAP devices cannot be extrapolated to support all. Further studies are required to validate the roles of APAP, C-Flex and A-Flex. In the interim, standard CPAP therapy should continue as the mainstay of OSAS management.


Files in this item

Thumbnail
Name:
20308751.pdf
Size:
638.8Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record